Skip to main content
OpenTrials
Completed

NCT Number: NCT04253197

Ultrasound Staging in the Placenta Accreta

The investigators evaluated the efficacy of a staging system introduced by the American Institute of ultrasound in medicine 2015 including sonographic parameters associated with morbidly adherent placenta for antenatal prediction of placental invasion.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obstetric Labor Complications Female Urogenital Diseases and Pregnancy Complications Pregnancy Complications Staging of Placental Invasion Urogenital Diseases

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Beni-Suef University

Cairo, 11211, Egypt

About this study

Morbidly adherent placenta (MAP) defines a spectrum of conditions, including placenta accreta, increta, and percreta, which are associated with significant maternal and fetal morbidity and mortality. Ultrasound evaluation, with grayscale, is the recommended first-line modality for diagnosing MAP. Grayscale ultrasound features suggestive of placenta accreta include the loss of myometrial interface or retroplacental clear space, reduced myometrial thickness and the presence of intraplacental lacunae. Using a staging system by antenatal ultrasound can predict placental invasion antenatally.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Prior lower segment cesarean section
  • Low lying anterior placenta
  • Singleton pregnancy

Exclusion criteria

  • Medical disorders
  • vasa previa

Treatment and study plan

Ultrasound

Device

Pregnant women in 3rd trimester with anterior placenta previa and lower cesarean section scar. Ultrasound was done and according to parameters of the morbidly adherent placenta, a staging system was conducted.

Primary outcomes

  1. Confirmation of the stage of myometrial placental invasion

    Time frame: 1 hour

    By ultrasound, placental invasion in myometrium was given a stage

Secondary outcomes

  1. Blood loss

    Time frame: 1 hour

    Documentation of complications intraoperative

Sponsors and collaborators

Lead sponsor

Beni-Suef University

Other

Registry information

Official study title

Efficacy of Ultrasound Staging System in Prediction of Morbidly Adherent Placenta

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Feb 5, 2020
Registry last updated
Feb 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.